Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Insect Antibiotics - Resistance is Futile!


Insect Antibiotic, Cecropin A, Bypasses Outer Defenses to Kill Bacteria From The Inside

For antibiotics, the best way to beat bacterial defenses may be to avoid them altogether. Researchers at University of Pennsylvania School of Medicine have discovered that Cecropin A, a member of a family of antibiotic proteins produced by insects, may kill bacteria and avoid resistance by entering bacterial cells and taking control of their genetic machinery.

While most antibiotics kill bacteria by attacking critical enzyme systems, Cecropin A somehow slips inside the bacteria and turns specific genes on and off. The findings challenge conventional thinking on how these antibiotics function, and may aid in turning antimicrobial peptides like Cecropin A into therapeutic agents.

"For decades, researchers have studied Cecropin A and focused on its obvious effects against bacterial cell walls and membranes. These antibiotics certainly do disrupt outer structures of the bacterial cell, but there’s much more to the story," said Paul H. Axelsen, M.D., an associate professor in the Department of Pharmacology and Division of Infectious Diseases at Penn. "Before the bacterial cell dies, Cecropin A enters the cell and alters the way its genes are regulated. It’s like sneaking over the castle wall and opening the gates from the inside. We need to understand this mechanism of action because it may explain why bacteria are unable to develop resistance to this family of antibiotics."

Axelsen’s findings were described in the January issue of the Antimicrobial Agents and Chemotherapy, a publication of the American Society for Microbiology. In their study, Axelsen and his colleagues treated E. coli with small doses of Cecropin A - not enough to kill the bacteria, but enough to see what genes are affected when bacteria are exposed to the antibiotic. They found that transcript levels for 26 genes are affected, 11 of which code for proteins whose functions are unknown. Even more surprising for the researchers, the genes are not the same as the ones affected when bacteria experience nutritional, thermal, osmotic, or oxidative stress.

"It is a whole different mechanism by which to kill bacteria, and one that we still have yet to completely figure out," said Axelsen. "How Cecropin A turns these genes on and, indeed, how it gets inside E. coli in the first place, is still something of a mystery."

Despite years of research, there remains much to know about the antibiotics produced by insects. Cecropin A was discovered in the Cecropia moth, also known as the silkworm moth, the largest moth in North America. Since insects do not have an immune system as humans do, they rely on polypeptide antibiotics like Cecropin A to fight off infections. These proteins are highly selective - they readily kill bacteria, but are harmless to human and other animal cells. Moreover, bacteria that are susceptible initially stay susceptible - researchers have not seen bacteria develop resistance to their action. For this reason, these antibiotics offer a potentially invaluable model for new therapeutic agents.

"We’re engaged in an arms race against infectious bacteria. With each new antibiotic, bacteria have found a way to evolve resistance - primarily by slightly altering cellular enzymes," said Axelsen. "Bacteria may be unable to alter their genetic machinery, and this may explain why strains of bacteria resistant to Cecropin A do not arise."

Funding for this research was supported by grants from the National Institutes of Health and the American Heart Association, and from Affymetrix’s generous donation of E. coli GeneChip Microarrays.

Greg Lester | University of Pennsylvania Medic
Further information:

More articles from Life Sciences:

nachricht ‘Farming’ bacteria to boost growth in the oceans
24.10.2016 | Max-Planck-Institut für marine Mikrobiologie

nachricht Calcium Induces Chronic Lung Infections
24.10.2016 | Universität Basel

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Light-driven atomic rotations excite magnetic waves

Terahertz excitation of selected crystal vibrations leads to an effective magnetic field that drives coherent spin motion

Controlling functional properties by light is one of the grand goals in modern condensed matter physics and materials science. A new study now demonstrates how...

Im Focus: New 3-D wiring technique brings scalable quantum computers closer to reality

Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.

"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...

Im Focus: Scientists develop a semiconductor nanocomposite material that moves in response to light

In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.

A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...

Im Focus: Diamonds aren't forever: Sandia, Harvard team create first quantum computer bridge

By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.

"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...

Im Focus: New Products - Highlights of COMPAMED 2016

COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.

In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...

All Focus news of the innovation-report >>>



Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

Agricultural Trade Developments and Potentials in Central Asia and the South Caucasus

14.10.2016 | Event News

World Health Summit – Day Three: A Call to Action

12.10.2016 | Event News

Latest News

Oasis of life in the ice-covered central Arctic

24.10.2016 | Earth Sciences

‘Farming’ bacteria to boost growth in the oceans

24.10.2016 | Life Sciences

Light-driven atomic rotations excite magnetic waves

24.10.2016 | Physics and Astronomy

More VideoLinks >>>